About
Neurological Treatments
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
509
By Phase
PHASE3: 2PHASE2/PHASE3: 1
By Status
COMPLETED: 3ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05043103Lead Sponsor
Long-Term Observational Study on Effectiveness and Safety of Lecigon in Patients with Advanced Parkinson's Disease
N/AActive, not recruiting
300 participants
Started: Jul 6, 2021 · Completed: Sep 30, 2026
NCT02006121Lead Sponsor
Clinical Trial of Apomorphine Subcutaneous Infusion in Patients With Advanced Parkinson's Disease
PHASE3Completed
107 participants
Started: Mar 3, 2014 · Completed: Jun 8, 2017
NCT00346827Lead Sponsor
"Apomorphine Nasal Powder in the Treatment of Parkinson's Disease Off Periods."
PHASE2/PHASE3Completed
36 participants
Started: Jul 31, 2006 · Completed: Aug 31, 2007
NCT00032942Collaborator
Lofexidine for Opiate Withdrawal - 1
PHASE3Completed
66 participants
Started: Apr 30, 2001
Locations (1)
Headquarters
Reading, UK
Map
Loading map...